Reference Value. Equity as reported in the selected filing.
UAB "Gydančios rankos" - Company Valuation
Reported Book Equity
40,321 €
Reference Value
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- D+
- Risks
- Loss-Making
Scope & Evidence
- Company
- UAB "Gydančios rankos"
- Registration
- LT · 301732821
- Covers
- Single Company
- Filings Used
- 11 · FY 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.18×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- -
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- -
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -227.0%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- -47.0%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- -
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- -8.7%
3-Year Revenue Scenarios
10k €
7.5k €
5k €
2.5k €
0 €
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- VIEŠOJI ĮSTAIGA PANEVĖŽIO FIZINĖS MEDICINOS IR REABILITACIJOS CENTRAS
- 4,233,338 €
- Uždaroji akcinė bendrovė "LORNA"
- 3,177,836 €
- UAB "Vilnijus"
- 487,682 €
- Kineziterapijos centras, UAB
- 485,955 €
- UAB "Alvinga LT"
- 58,744 €
- UAB "Terapika"
- 25,120 €
- UAB "Gydančios rankos" ★
- 8,340 €
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
60k €
40k €
20k €
0 €
-20k €
20212022202320242025
RevenueNet Profit
Versus Industry Median
30k €
15k €
0 €
-15k €
-30k €
RevenueNet Profit
This CompanyIndustry Median